Teva Pharma (NYSE: TEVA) announced that the Russian Ministry of Health has approved the Marketing Authorization license (MA) for three-times-a-week ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE